Effect of SGLT2 inhibitors in sustained ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators for primary prevention

Back

HFA Premium Access

Effect of SGLT2 inhibitors in sustained ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators for primary prevention

Session: Arrhythmias & device

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Mr J. Lopes (Lisbon, PT)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Mr Julien Lopes

Hospital de Santa Marta, Lisbon (Portugal)

0 follower

6 more presentations in this session

Transvenous lead extraction: application of the Tandem approach in patients with heart failure

Speaker: Professor M. Gallagher (London, GB)

Long term prognosis of idiopathic ventricular arrhythmias: an eighteen-year experience from a tertiary center

Speaker: Doctor C. Oliveira (Porto, PT)

Unmasking the hidden threat: non-sustained ventricular tachycardia in pacemaker patients with HFpEF and its prognostic significance on mortality and heart failure events

Speaker: Miss E. Santos (Vila Nova de Gaia, PT)

Implantable cardioverter defibrillators in heart failure with reduced ejection fraction: evaluating efficacy in the era of contemporary pharmacotherapy

Speaker: Doctor I. Ferreira Neves (Lisboa, PT)

Machine learning-based mortality prediction in patients undergoing CRT implantation using the SEMMELWEIS-CRT score: validation in the European CRT survey I database

Speaker: Doctor M. Tokodi (Budapest, HU)

Access the full session

Arrhythmias & device

Speakers: Mr J. Lopes, Professor M. Gallagher, Doctor C. Oliveira, Miss E. Santos, Doctor I. Ferreira Neves...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources